Disease: Diffuse Large B-cell Lymphoma
- A case of cutaneous variant of intravascular large B-cell lymphoma in which dermoscopy revealed telangiectasias associated with erythematous induration
- A case of diffuse large B-cell lymphoma with decompensated alcohol-related liver cirrhosis treated successfully by chemoimmunotherapy
- A Case of Esophageal MALT Lymphoma Mimicking a Subepithelial Tumor
- A case of methotrexate-related lymphoproliferative disease showing multiple liver lesions in a patient with rheumatoid arthritis
- A case of primary central nervous system lymphoma of the sellar region presented with panhypopituitarism
- A multi-instance tumor subtype classification method for small PET datasets using RA-DL attention module guided deep feature extraction with radiomics features
- Adult Ileoileal Intussusception Caused by Diffuse Large B-cell Lymphoma()
- An Early Neurological Indicator of Immune Effector Cell-Associated Neurotoxicity Syndrome
- ASCT2-Targeting Antibody-Drug Conjugate MEDI7247 in Adult Patients with Relapsed/Refractory Hematological Malignancies: A First-in-Human, Phase 1 Study
- Assessment and prognostic significance of a serum cytokine panel in diffuse large B-cell lymphoma
- Bilateral Cytomegalovirus Retinitis After Chimeric Antigen Receptor T-cell Therapy for B-cell Lymphoma
- CAR-T cell therapy: unravelling its potential in extra-nodal diffuse large B cell lymphoma
- Case report: Mutation evolution in a patient with TdT positive high grade B cell lymphoma with MYC and BCL2 rearrangements following the treatment of concurrent follicular lymphoma and diffuse large B-cell lymphoma
- CD58 alterations govern antitumor immune responses by inducing PD-L1 and IDO in diffuse large B-cell lymphoma
- CHIMERIC ANTIGEN RECEPTOR T CELLS (CAR-T CELLS) THERAPY FOR B-CELL HEMATOLOGICAL MALIGNANCIES - FROM THE ISRAELI SOCIETY OF HEMATOLOGY AND TRANSFUSION MEDICINE
- Circulating Tumor DNA in Diffuse Large B-Cell Lymphoma: from Bench to Bedside?
- Clinical characteristics and prognostic analysis of primary extranodal non-Hodgkin lymphoma of the head and neck
- Clinical Features and Prognostic Analysis of Newly Diagnosed Diffuse Large B-cell Lymphoma Combined with Hemophagocytic Syndrome
- Clinical Features of Non-Hodgkin Lymphoma-Associated Hemophagocytic Syndrome: a Retrospective Study
- Combination of Tractography, Intraoperative Computed Tomography and 5-Aminolevulinic Acid Fluorescence in Stereotactic Brain Biopsies: A Case Series
- Combinational therapy of CAR T-cell and HDT/ASCT demonstrates impressive clinical efficacy and improved CAR T-cell behavior in relapsed/refractory large B-cell lymphoma
- Complete response to front-line therapies is associated with long-term survival in HIV-related lymphomas in Taiwan
- Contrast-Enhanced Ultrasonography in Diagnosing Intravascular Large B-Cell Lymphoma Infiltrating Liver Sinusoids
- Conventional and novel [(18)F]FDG PET/CT features as predictors of CAR-T cell therapy outcome in large B-cell lymphoma
- Correlation Analysis of Peripheral Blood B Cell Count with Clinical Features and Prognosis in Patients Newly Diagnosed with Diffuse Large B-Cell Lymphoma
- Cytological Features of Fibrin-associated Diffuse Large B-cell Lymphoma Arising in Retroperitoneal Pseudocyst: The First Case Report
- Deciphering the Prognostic Significance of MYD88 and CD79B Mutations in Diffuse Large B-Cell Lymphoma: Insights into Treatment Outcomes
- Derangements of immunological proteins in HIV-associated diffuse large B-cell lymphoma: the frequency and prognostic impact
- Diffuse large B-cell lymphoma in Peri-implant tissues following lumbar spinal fusion surgery: A case report and literature review
- Discovery of novel pyridone-benzamide derivatives possessing a 1-methyl-2-benzimidazolinone moiety as potent EZH2 inhibitors for the treatment of B-cell lymphomas
- Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-cell Lymphoma
- Early CAR(-) CD4(+) T-lymphocytes recovery following CAR-T cell infusion: A worse outcome in diffuse large B cell lymphoma
- Early evaluation of CAR-T cell therapy response in R/R DLBCL patients using <sup>18</sup>F-FDG PET/CT
- Efficacy and safety of bendamustine for lymphodepletion before lisocabtagene maraleucel
- Epstein-Barr-Virus-Related Lymphoproliferative Disorder in a Patient With Primary Myelofibrosis: A Case Report and Literature Review
- Experience of multi-disciplinary treatment of multiple cerebellar diffuse large B-cell lymphoma: A case report
- Expression of CD30 in Patients with Diffuse Large B-Cell Lymphoma and Clinical Significance
- Finding the needle in a haystack: single-balloon enteroscopy to diagnose diffuse large B-cell lymphoma
- First Use of Upfront Polatuzumab Vedotin in Post-transplant Lymphoproliferative Disorder: A Case Report
- Gingival diffuse large B-cell lymphoma: report of 2 cases
- Graft-versus-host disease after autologous stem cell transplantation in a recipient who underwent allogeneic stem cell transplantation 20 years earlier
- Hepatic Tumor Rupture in Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders of the B-cell Type in a Patient With Chronic Rheumatoid Arthritis
- High PPP4C expression predicts poor prognosis in diffuse large B-cell lymphoma
- Higher Mortality in Patients With Diffuse Large B-cell Lymphoma Pre-Existing Arterial Hypertension-Real World Data of the Polish Lymphoma Research Group
- HLA variations in patients with diffuse large B-cell lymphoma and association with disease risk and prognosis: a case-control study
- Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas
- Identification of a novel form of caspase-independent cell death triggered by BH3-mimetics in diffuse large B-cell lymphoma cell lines
- Identification of a Patient Suitable for CAR-T Cell Therapy in the Outpatient Setting: A Vodcast and Case Example
- Impact of Demographics and Neighborhood Socioeconomic Variables on Clinical Trial Participation in Non-Hodgkin Lymphoma
- Laparoscopic Radical Total Gastrectomy and Pancreatosplenectomy for Synchronous Cancer of the Stomach and Pancreas
- LINC01614 is a promising diagnostic and prognostic marker in HNSC linked to the tumor microenvironment and oncogenic function
- Long-term remission after upfront autologous hematopoietic stem cell transplant for CD5(+) diffuse large-B cell lymphoma
- Metabolic signature and response to glutamine deprivation are independent of p53 status in B cell malignancies
- Metastases and Primary Brain Tumors Affecting the Fornix of the Brain
- MNDA expression and its value in differential diagnosis of B-cell non-Hodgkin lymphomas: a comprehensive analysis of a large series of 1293 cases
- Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B Cell Lymphoma
- Molecular Features of HHV8 Monoclonal Microlymphoma Associated with Kaposi Sarcoma and Multicentric Castleman Disease in an HIV-Negative Patient
- Multifocal Primary Extranodal Non-Hodgkin Lymphoma: A Report of a Rare Case
- Mutant FOXO1 controls an oncogenic network via enhancer accessibility
- Mutation landscape in Chinese nodal diffuse large B-cell lymphoma by targeted next generation sequencing and their relationship with clinicopathological characteristics
- New Insights into First-Line Therapy in Diffuse Large B-Cell Lymphoma: Are We Improving Outcomes?
- New insights into possible HDAC inhibitor resistance in DLBCL - Comment on 'defining cellular responses to HDAC-selective inhibitors reveals that efficient targeting of HDAC3 is required to elicit cytotoxicity and overcome naive resistance to pan-HDA
- Nonbacterial thrombotic endocarditis of mitral valve associated with a lymphoproliferative malignancy: case report and literature review
- Outcomes of the transformation of follicular lymphoma to diffuse large B-cell lymphoma in the rituximab era: A population-based study
- Persistent Cytopenia After CD19 CAR T Therapy in Relapsed/Refractory DLBCL Patients Could Be a Predictor of Efficacy and Side Effects
- Poor outcomes for trial-ineligible patients receiving polatuzumab for relapsed/refractory diffuse large B-cell lymphoma in routine care: An Australian Lymphoma and Related Diseases Registry project
- Population pharmacokinetics and exposure-response analyses of polatuzumab vedotin in patients with previously untreated DLBCL from the POLARIX study
- Predictive Value of Corrected <sup>18</sup> F-FDG PET/CT Baseline Parameters for Primary DLBCL Prognosis: A Single-center Study
- Predictors of Survival, Treatment Modalities, and Clinical Outcomes of Diffuse Large B-Cell Lymphoma in Patients Older Than 70 Years Still an Unmet Medical Need in 2024 Based on Real-World Evidence
- Primary Extranodal Diffuse Large B-cell Lymphoma Presenting in the Lips: A Case Report and Literature Review
- Primary gastric diffuse large B-cell lymphoma: A multicentre retrospective study
- Primary Large B-cell Lymphomas of Immune-Privileged Sites
- Primary lymphoma of the female genital tract masquerading as gynecological malignancy
- Prognosis Prediction of Diffuse Large B-cell Lymphoma in (18)F-FDG PET images Based on Multi-Deep-Learning Models
- Pyogenic spondylitis after Corynebacterium striatum blood stream infection following allogeneic hematopoietic stem cell transplantation for malignant lymphoma
- Real-World Challenges of Managing Diffuse Large B-Cell Lymphoma in a Developing Country
- Real-world patient characteristics, treatment patterns, and treatment outcomes of patients with diffuse large B-cell lymphoma by line of therapy
- Real-world status of treatment for lymphoid neoplasms developed during the course of myeloproliferative neoplasms in Japan
- Real-world total cost of care by line of therapy in relapsed/refractory diffuse large B-Cell lymphoma
- Recombinant hirudin suppresses angiogenesis of diffuse large B-cell lymphoma through regulation of the PAR-1-VEGF
- Richter Syndrome Presenting as Subcutaneous Nodules and a Dermal Plaque
- Ruptured Baker Cyst on 18F-FDG PET/CT
- Safety and biologic activity of a canine anti-CD20 monoclonal antibody in dogs with diffuse large B-cell lymphoma
- Sequencing of anti-CD19 therapies in the management of diffuse large B-cell lymphoma
- Shared genetic factors and causal association between chronic hepatitis C infection and diffuse large B cell lymphoma
- SLC27A2 is a potential immune biomarker for hematological tumors and significantly regulates the cell cycle progression of diffuse large B-cell lymphoma
- Solitary large malignant lymphoma in the head and neck region
- Specific mortality in patients with diffuse large B-cell lymphoma: a retrospective analysis based on the surveillance, epidemiology, and end results database
- Splenic Pseudoprogression After CAR-T Therapy Detected by 18F-FDG PET/CT in a Refractory Diffuse Large B-Cell Lymphoma Patient
- Spontaneous regression and rare relapse after excisional biopsy in long-term observation of 31 patients with primary conjunctival lymphoma
- Structure and function of therapeutic antibodies approved by the US FDA in 2023
- Targeting the tumor microenvironment in primary central nervous system lymphoma: Implications for prognosis
- The disease under chronic urticaria: beyond itching
- The impact of race and ethnicity on diffuse large B-cell lymphoma outcomes within the veterans health administration (VHA)
- The Impact of Tumor Hypoxia Modulation on sIL-2R Levels in Newly Diagnosed Diffuse Large B Cell Lymphoma (DLBCL) Patients Undergoing Chemotherapy: A Randomized Clinical Trial
- The Small Round Blue Cell Tumors of Sinonasal Tract: Pathologists Grey Zone
- The Value of Baseline PET/CT Imaging of Bone Marrow <sup>18</sup>F-FDG Uptake Pattern in Predicting Prognosis of DLBCL
- TRAF3 loss-of-function reveals the noncanonical NF-kappaB pathway as a therapeutic target in diffuse large B cell lymphoma
- Unusual US Findings of Diffuse Large B-Cell Lymphoma of the Breast: A Case Report
- XPO1 blockade with KPT-330 promotes apoptosis in cutaneous T-cell lymphoma by activating the p53-p21 and p27 pathways